- CEO
- Xingru He
- Full Time Employees
- 3,174
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Shenyang China
- IPO Date
- Mar 22, 2022
- Business
- Liaoning He Eye Hospital Group Co., Ltd. is a China-based medical services enterprise that provides comprehensive ophthalmic and optometry healthcare services, ophthalmic medical device distribution, and digital eye health management solutions. Founded in 1995 and headquartered in Shenyang, Liaoning Province, the company operates an integrated healthcare network structured around a three-tier eye care delivery system that connects regional tertiary eye hospitals with local specialty clinics and community vision centers.
The company organizes its business operations primarily into two core segments: Medical Services and Optometry Services. Its clinical healthcare portfolio encompasses refractive surgical procedures, including laser-assisted in situ keratomileusis (LASIK), full-femtosecond laser surgery, and implantable collamer lens (ICL) implantation; cataract surgical treatments, comprising standard phacoemulsification, refractive cataract surgery, and premium multifocal and toric intraocular lens (IOL) implantations; complex ocular disease treatments, which cover vitreoretinal disease management, surgical and medical therapies for glaucoma, diabetic retinopathy interventions, corneal and external eye disease treatments, strabismus and amblyopia correction, ocular trauma surgery, orbital disease care, and integrated Traditional Chinese Medicine (TCM) ophthalmic therapies; and specialized dry eye disease management, offering pulsed light therapies, meibomian gland physical treatments, and customized ocular surface regimens. Within its optometry division, the company provides adolescent myopia prevention and control services; comprehensive vision examination and refractive testing; prescription spectacles and optical frames; specialized orthokeratology (OK) contact lenses; proprietary functional lenses under the Zhaoxi and Zhaoyue product lines; custom soft and rigid gas-permeable contact lenses; visual function rehabilitation training; and the wholesale and retail distribution of ophthalmic consumables, optical diagnostic instruments, and related healthcare products.
Geographically, Liaoning He Eye Hospital Group maintains a strong market presence in Northeast China while systematically expanding its hospital and vision center network across key economic clusters, including the Beijing-Tianjin-Hebei region, the Yangtze River Delta, the Guangdong-Hong Kong-Macao Greater Bay Area, and the Chengdu-Chongqing metropolitan area.
In recent developments, the company has accelerated its asset-light expansion by introducing a specialized franchise model alongside direct-operated optometry clinics to broaden nationwide grassroots coverage. The group has advanced its digital transformation and artificial intelligence initiatives under its Smart City of Light strategy, integrating big data, AI-assisted diagnostic screening tools, and telemedicine platforms to facilitate whole-lifecycle ocular health management. On the research front, the company was approved to lead a national key research and development project focused on proactive healthcare and aging management, developing intelligent biometric health identification systems based on ocular and facial features. Additionally, the group earned international recognition as an accredited ophthalmic physician training institution from the International Ophthalmology Foundation (OF), progressed cross-border overseas acquisition initiatives, and executed corporate share repurchase programs to support long-term equity incentive frameworks.